Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment

Autor: Jay-Shake Li, Yung-I Lou, Che-Yu Lin, Yung-Chih Kuo
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Pharmaceutical Science
02 engineering and technology
blood–brain barrier
Hippocampus
Receptor tyrosine kinase
chemistry.chemical_compound
Drug Delivery Systems
International Journal of Nanomedicine
Drug Discovery
Cardiolipin
Phosphorylation
Original Research
Neurons
β-amyloid
Kinase
Neurodegeneration
neurodegeneration
Brain
General Medicine
021001 nanoscience & nanotechnology
Immunohistochemistry
medicine.anatomical_structure
Biochemistry
liposome
0210 nano-technology
Alzheimer’s disease
Curcumin
Cardiolipins
Cell Survival
Wheat Germ Agglutinins
p38 mitogen-activated protein kinases
Static Electricity
Biophysics
tau Proteins
Bioengineering
Biology
Fluorescence
Biomaterials
03 medical and health sciences
Alzheimer Disease
medicine
Animals
Humans
Particle Size
Rats
Wistar

Amyloid beta-Peptides
Nervous tissue
wheat germ agglutinin
Organic Chemistry
JNK Mitogen-Activated Protein Kinases
medicine.disease
Molecular biology
Wheat germ agglutinin
Kinetics
stomatognathic diseases
030104 developmental biology
Nerve growth factor
chemistry
Liposomes
Nerve Degeneration
biology.protein
Zdroj: International Journal of Nanomedicine
ISSN: 1178-2013
DOI: 10.2147/ijn.s128396
Popis: Yung-Chih Kuo,1 Che-Yu Lin,1 Jay-Shake Li,2 Yung-I Lou3 1Department of Chemical Engineering, 2Department of Psychology, National Chung Cheng University, Chia-Yi, 3Department of Accounting, Providence University, Taichung, Taiwan, Republic of China Abstract: Curcumin (CRM) and nerve growth factor (NGF) were entrapped in liposomes (LIP) with surface wheat germ agglutinin (WGA) to downregulate the phosphorylation of kinases in Alzheimer’s disease (AD) therapy. Cardiolipin (CL)-conjugated LIP carrying CRM (CRM-CL/LIP) and also carrying NGF (NGF-CL/LIP) were used with AD models of SK-N-MC cells and Wistar rats after an insult with β-amyloid peptide (Aβ). We found that CRM-CL/LIP inhibited the expression of phosphorylated p38 (p-p38), phosphorylated c-Jun N-terminal kinase (p-JNK), and p-tau protein at serine202 and prevented neurodegeneration of SK-N-MC cells. In addition, NGF-CL/LIP could enhance the quantities of p-neurotrophic tyrosine kinase receptor type 1 and p-extracellular signal-regulated kinase 5 for neuronal rescue. Moreover, WGA-grafted CRM-CL/LIP and WGA-grafted NGF-CL/LIP significantly improved the permeation of CRM and NGF across the blood–brain barrier, reduced Aβ plaque deposition and the malondialdehyde level, and increased the percentage of normal neurons and cholinergic activity in the hippocampus of AD rats. Based on the marker expressions and in vivo evidence, current LIP carriers can be promising drug delivery systems to protect nervous tissue against Aβ-induced apoptosis in the brain during the clinical management of AD. Keywords: liposome, Alzheimer’s disease, β-amyloid, neurodegeneration, blood–brain barrier, wheat germ agglutinin
Databáze: OpenAIRE